Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Acta Pharmaceutica Sinica. B
|
January 23, 2024
A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance
Lei Sun, Arabella H Wan, Shijia Yan, et al.
Nature Communications
|
November 29, 2016
Amplification of USP13 drives ovarian cancer metabolism
Cecil Han, Lifeng Yang, Hyun Ho Choi, et al.
Cancer Immunology Research
|
October 20, 2025
HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration
Chuwei Liu, Heng Liang, Peipei Wang, et al.
Gut
|
November 21, 2020
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
Lei Sun, Arabella Wan, Zhuolong Zhou, et al.
Nature Communications
|
May 16, 2023
Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity
Bei Wang, Arabella H Wan, Yu Xu, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2022
<i>FOXO3</i> mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
Shaoxing Guan, Xi Chen, Youhao Chen, et al.
Cell Reports. Medicine
|
May 9, 2026
Dual-system engineered bacteria and dendritic cells enable precise intratumoral IL-12 delivery and potent antitumor immunity
Yuan Deng, Heng Liang, Arabella H Wan, et al.
Nature
|
August 26, 2021
Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu, Xinna Zhang, Cecil Han, et al.
Nature
|
April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu, Xinna Zhang, Cecil Han, et al.
Gastroenterology
|
December 8, 2023
Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer
Lei Sun, Ruonian Liu, Zong-Jian Wu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Acta Pharmaceutica Sinica. B
|
January 23, 2024
A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance
Lei Sun, Arabella H Wan, Shijia Yan, et al.
Nature Communications
|
November 29, 2016
Amplification of USP13 drives ovarian cancer metabolism
Cecil Han, Lifeng Yang, Hyun Ho Choi, et al.
Cancer Immunology Research
|
October 20, 2025
HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration
Chuwei Liu, Heng Liang, Peipei Wang, et al.
Gut
|
November 21, 2020
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
Lei Sun, Arabella Wan, Zhuolong Zhou, et al.
Nature Communications
|
May 16, 2023
Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity
Bei Wang, Arabella H Wan, Yu Xu, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2022
<i>FOXO3</i> mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy
Shaoxing Guan, Xi Chen, Youhao Chen, et al.
Cell Reports. Medicine
|
May 9, 2026
Dual-system engineered bacteria and dendritic cells enable precise intratumoral IL-12 delivery and potent antitumor immunity
Yuan Deng, Heng Liang, Arabella H Wan, et al.
Nature
|
August 26, 2021
Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu, Xinna Zhang, Cecil Han, et al.
Nature
|
April 23, 2015
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu, Xinna Zhang, Cecil Han, et al.
Gastroenterology
|
December 8, 2023
Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer
Lei Sun, Ruonian Liu, Zong-Jian Wu, et al.
Page
of 7